pharmaceuticals

Business

AstraZeneca quarterly net profit rises 2% on strong cancer drug sales

Strong cancer drug sales lifted Anglo-Swedish pharmaceutical giant AstraZeneca’s second-quarter earnings above expectations, helping the company maintain its 2026 outlook.

27 July 2026

Health news

EU ministers reach consensus on Biotech Act directive

Amid Europe’s push to catch up in the biotechnology field, the EU health ministers agreed how to tweak rules on modified micro-organisms (GMMs) and the processing of organs.

17 June 2026

Health news

EU health chief to probe effects of Trump’s drug pricing push

The EU health ministers have tasked the European Health Commissioner to assess the impact of the US’ most-favourite-nation policy on the bloc.

16 June 2026

The Big Question

The rising threat of antimicrobial resistance and its economic toll

More people are expected to die every year from superbugs than cancer by 2050. Antibiotic resistance is ‘a major threat’ to our health and economy, according to Japanese pharma experts.

18 May 2026

The Ring

Europe’s healthcare - A right or a business? MEPs debate in The Ring

In this special edition of The Ring, broadcast from the Euronews Health Summit, MEPs Stine Bosse (Renew Europe) and Tilly Metz (The Greens/EFA) go head-to-head to debate who should pay for European health innovation.

18 March 2026

Health news

EU's ‘unique’ healthcare system under pressure, says EU Commissioner

Simplification is key to boosting Europe’s healthcare competitiveness, fostering innovation, and reaching patients across the region, according to European Health Commissioner Olivér Várhelyi.

17 March 2026

Health news

Experimental oral drug lowers ‘bad’ cholesterol by 60%, study finds

A new pill in the final phase of clinical trials cuts harmful cholesterol by 60% in high-risk patients.

5 February 2026

Health news

Why weight loss drugs aren't Denmark's trump card in Greenland dispute

Novo Nordisk, the Danish manufacturer of weight-loss drugs Ozempic and Wegovy, has a large market share in the US. But it's not enough to put pressure on US President Donald Trump's administration during Greenland talks, experts say.

2 February 2026

Health news

EU unveils new pharma package to boost industry

The European Union has agreed on new pharmaceutical rules introducing new incentives to boost the pharmaceutical industry amid accessibility concerns.

11 December 2025

Business

UK and US agree on zero-tariff pharma deal after months of tensions

London and Washington have found a compromise that would avoid US tariffs on British medicines — but only after the UK agreed to pay more for cutting-edge drugs.

1 December 2025

Business

Pharma market shake-up: Bayer jumps, Novo Nordisk sinks 10%

Shares of Danish pharmaceutical giant Novo Nordisk fell sharply after its Alzheimer's drug failed to slow progression of the disease in a trial. Meanwhile, Germany's Bayer said their stroke-prevention drug showed positive results, pushing the share price through the roof.

24 November 2025

Healthcare

New malaria treatment could fight growing threat of drug resistance

Drugmaker Novartis said it will move quickly to ask regulators to approve the new medicine.

13 November 2025

Business

Markets exhale as Novo Nordisk withdraws from Metsera bidding war

Equity markets delivered a mixed response after Pfizer won the bidding war for anti-obesity drugmaker Metsera, as Metsera’s shares slipped but Novo Nordisk’s stock rose on news it was bowing out of the race.

11 November 2025

Germany

This is how dependent Germany is on Chinese medicines

Germany sold more than 15 million tonnes of pharmaceutical products to China in 2024, while China sold more than 33 million tonnes to Germany.

29 October 2025

Business

Pfizer agrees to lower prescription drug costs for Medicaid

Under the deal, New York-based Pfizer will charge most-favoured-nation pricing to Medicaid and guarantee that pricing on newly launched drugs, Trump said. That involves matching the lowest price offered in other developed nations.

1 October 2025

Business

Big Pharma’s retreat: Is NHS pricing behind investor pullbacks?

Multinational pharmaceutical firms are pulling pack or pausing investments in the UK, blaming a lack of competitive drug pricing.

30 September 2025